Elisabeth Turpin

1.0k citations

17 papers · 810 indexed · h-index 13

Co-authors: Hugues de Thé Anne Janin Louis‐François Plassa Philippe Bertheau Marc Espié Mariana Varna Jacqueline Lehmann‐Che Anne de Roquancourt
Topics: Cancer-related Molecular Pathways (7 papers)Cancer Genomics and Diagnostics (5 papers)Toxin Mechanisms and Immunotoxins (4 papers)
Cited by: Cancer Research Oncology Biotechnology
Journals: Blood Diabetes Care Cancer Research
Partner nations: France United States Morocco

In The Last Decade

Elisabeth Turpin

17 papers receiving 790 citations

Peers

Countries citing papers authored by Elisabeth Turpin

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Turpin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Turpin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Turpin more than expected).

Fields of papers citing papers by Elisabeth Turpin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Turpin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Turpin. The network helps show where Elisabeth Turpin may publish in the future.

Co-authorship network of co-authors of Elisabeth Turpin

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Turpin. A scholar is included among the top collaborators of Elisabeth Turpin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Turpin. Elisabeth Turpin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	p53 in breast cancer subtypes and new insights into response to chemotherapy 2013 ·The Breast ·Philippe Bertheau,Jacqueline Lehmann‐Che,Mariana Varna,Anne Dumay,Brigitte Poirot,Raphaël Porcher,Elisabeth Turpin,Louis‐François Plassa,Anne de Roquancourt,E. Bourstyn,Patricia de Crémoux,Anne Janin,Sylvie Giacchetti,Marc Espié,Hugues de Thé	151
2	Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder 2011 ·Urologic Oncology Seminars and Original Investigations ·Francis Dubosq,Guillaume Ploussard,Hany Soliman,Elisabeth Turpin,Alain Latil,François Desgrandchamps,Hugues de Thé,P. Mongiat-Artus	14
3	Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of p53 Mutant Breast Cancers 2010 ·The Oncologist ·Jacqueline Lehmann‐Che,Fabrice André,Christine Desmedt,Chafika Mazouni,Sylvie Giacchetti,Elisabeth Turpin,Marc Espié,Louis‐François Plassa,Michel Marty,Philippe Bertheau,Christos Sotiriou,Martine Piccart,W. Fraser Symmans,Lajos Pusztai,Hugues de Thé	41
4	High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors 2009 ·Cancer Research ·Élodie Manié,Anne Vincent‐Salomon,Jacqueline Lehmann‐Che,Gaëlle Pierron,Elisabeth Turpin,Mathilde Warcoin,Nadège Gruel,Ingrid Lebigot,Xavier Sastre‐Garau,Rosette Lidereau,Audrey Remenieras,Jean Feunteun,Olivier Delattre,Hugues de Thé,Dominique Stoppa‐Lyonnet,Marc‐Henri Stern	112
5	p53 dependent cell‐cycle arrest triggered by chemotherapy in xenografted breast tumors 2008 ·International Journal of Cancer ·Mariana Varna,Jacqueline Lehmann‐Che,Elisabeth Turpin,Elisabetta Marangoni,(unknown),Marion Jeanne,(unknown),Philippe Ratajczak,Christophe Lebœuf,Louis‐François Plassa,Irmine Ferreira,Marie‐France Poupon,Anne Janin,Hugues de Thé,Philippe Bertheau	39
6	<i>TP53</i> Status and Response to Chemotherapy in Breast Cancer 2008 ·Pathobiology ·Philippe Bertheau,Marc Espié,Elisabeth Turpin,(unknown),Louis‐François Plassa,Mariana Varna,Anne Janin,Hugues de Thé	90
7	Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen 2007 ·PLoS Medicine ·Philippe Bertheau,Elisabeth Turpin,David S. Rickman,Marc Espié,Aurélien de Reyniès,Jean‐Paul Feugeas,Louis‐François Plassa,Hany Soliman,Mariana Varna,Anne de Roquancourt,Jacqueline Lehmann‐Che,Yves Beuzard,M. Marty,Jean-Louis Misset,Anne Janin,Hugues de Thé	132
8	La fonction de TP53 2007 ·médecine/sciences ·Jacqueline Lehmann‐Che,Elisabeth Turpin,Philippe Bertheau,Marc Espié,Hugues de Thé	3
9	Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma 2003 ·Blood ·Weili Zhao,Marjan Daneshpouy,Nicolas Mounier,Josette Brière,Christophe Lebœuf,Louis‐François Plassa,Elisabeth Turpin,Jean‐Michel Cayuela,Jean‐Claude Ameisen,Christian Gisselbrecht,Anne Janin	53
10	Allelic Loss Detection in Inflammatory Breast Cancer: Improvement with Laser Microdissection 2001 ·Laboratory Investigation ·Philippe Bertheau,(unknown),Florence Lerebours,Anne de Roquancourt,Elisabeth Turpin,Rosette Lidereau,Hugues de Thé,Anne Janin	30
11	Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers 1999 ·Oncogene ·Elisabeth Turpin,B Dalle,Anne de Roquancourt,(unknown),Michel Marty,Anne Janin,Yves Beuzard,Hugues de Thé	26
12	In adrenocortical tissue, annexins II and VI are attached to clathrin coated vesicles in a calcium-independent manner1In memoriam: This last work as well as my scientific accomplishment are dedicated to the memory of Jeffries Wyman who was my best teacher and the most humane of all scientists I have ever met. Annette Alfsen.1 1998 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Elisabeth Turpin,Françoise Russo‐Marie,Thierry Dubois,(unknown),Annette Alfsen,Morgane Bomsel	48
13	Lipoprotein(a) in Diabetic Patients and Normoglycemic Relatives in Familial NIDDM 1993 ·Diabetes Care ·Gilberto Velho,(unknown),Elisabeth Turpin,Dominique Néel,Daniel Cohen,Philippe Froguel,P Passa	37
14	Separation of ricin A- and B-chains after dithiothreitol reduction 1988 ·Analytical Biochemistry ·Florence Emmanuel,Elisabeth Turpin,Annette Alfsen,Jean‐Pierre Frénoy	16
15	Nature of the interaction between Ricinus communis agglutinin and blood cells 1984 ·FEBS Letters ·Elisabeth Turpin,Jean‐Pierre Frénoy,(unknown)	2
16	Nature of the receptor sites for galactosyl-specific lectins on human lymphocytes 1984 ·Experimental Cell Research ·Elisabeth Turpin,(unknown),Halina Lis,Nathan Sharon	9
17	Interaction between the Ricinus sanguineus agglutinin and receptor sites isolated from normal human lymphocytes 1979 ·Biochimie ·(unknown),Elisabeth Turpin,Dominique Néel,(unknown),R Bourrillon	7

About Elisabeth Turpin

Elisabeth Turpin is a scholar working on Cancer Research, Oncology and Immunology, having authored 17 papers that have together received 810 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Cancer Genomics and Diagnostics (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). The work is most often cited by research in Cancer Research (320 citations), Oncology (431 citations) and Biotechnology (68 citations). Elisabeth Turpin has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include Hugues de Thé, Anne Janin, Louis‐François Plassa, Philippe Bertheau, Marc Espié, Mariana Varna, Jacqueline Lehmann‐Che, Anne de Roquancourt, Sylvie Giacchetti and Yves Beuzard. Their work appears in journals such as Blood, Diabetes Care and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact